Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The QuickStart Study: Same-visit Hepatitis C Testing and Treatment
NCT05016609Phase 4Unknown
- Sponsor
- Burnet Institute
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir + velpatasvir in hepatitis C (HCV), sponsored by Burnet Institute. Status: unknown.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT05016609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016609.